Trials / Terminated
TerminatedNCT03161509
Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy
Effect of Sleeve Gastroctomy on Pharmacokinetics of Paracetamol and Antiepileptic Drugs
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol and antiepileptic drugs before and 6 months after sleeve gastrectomy.
Detailed description
Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol (in consenting subjects that are undergoing sleeve gastrectomy) and antiepileptic drugs (in consenting subjects that are chronically treated by a stable dose) before and 6 months after sleeve gastrectomy in 10 subjects. Blood tests will be taken for drug levels before and 4-8 times after the subject takes the drug. A pharmacokinetic curve will be calculated and compared for each subject between prior to surgery and after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracetamol | single dose of 1 gr paracetamol |
| DRUG | Antiepileptic (either carbamazepine, lamotrigine, phenytoin or valproic acid) | Single dose of antiepileptic drug (either carbamazepine, lamotrigine, phenytoin or valproic acid) for which the participant is taking chronically in stable dose |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2018-12-01
- Completion
- 2019-01-01
- First posted
- 2017-05-19
- Last updated
- 2021-09-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03161509. Inclusion in this directory is not an endorsement.